cancer Archives | Page 5 of 9 | Be Korea-savvy
More Than Half of Male Cancer Patients Continue to Smoke After Initial Diagnosis

More Than Half of Male Cancer Patients Continue to Smoke After Initial Diagnosis

SEOUL, Jul. 25 (Korea Bizwire) — More than half of male smokers in South Korea continue to smoke even after being diagnosed with cancer, a recent study has revealed. A research team from the Seoul National University Bundang Hospital studied 15,000 male patients over 40 years of age who were initially diagnosed with cancer between [...]

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, Supported by Helsinn, Awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, Supported by Helsinn, Awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

Lugano, Switzerland, Jun. 1 (Korea Bizwire) – Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, in conjunction with the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO), today announces Allison Barz Leahy, MD, University of Pennsylvania, as the recipient of the Anna Braglia Endowed Young Investigator Award in [...]

Cancer Deaths Up 72 pct Over Past Ten Years

Cancer Deaths Up 72 pct Over Past Ten Years

SEOUL, May 2 (Korea Bizwire) – Cancer deaths have increased by 72 percent in the past decade, with lung cancer being most commonly diagnosed, followed by liver, stomach, pancreas, colon and breast cancer. According to the Korea Insurance Development Institute on Wednesday, the number of life insurance subscribers who died of cancer increased from 18,144 [...]

Combination of First-in-class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in vivo Models of Lung Cancer

Combination of First-in-class NBTXR3, Radiotherapy, and Anti-PD-1 Immunotherapy Demonstrate Efficacy in Treating Resistant Pre-clinical in vivo Models of Lung Cancer

Paris, France; Cambridge, Massachusetts (USA); Apr. 2 (Korea Bizwire) – NANOBIOTIX (Euronext: NANO – ISIN: FR0011341205 – the ‘‘Company’’) a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced preclinical data from studies currently being conducted under its collaborations with The University of Texas MD Anderson Cancer Center and the Weill Cornell [...]

S. Korea Builds Memorial Park for Children Who Succumb to Cancer

S. Korea Builds Memorial Park for Children Who Succumb to Cancer

SEOUL, Feb. 13 (Korea Bizwire) — A Children’s Memorial Park, where children who pass away after suffering from cancer and leukemia can rest in peace, will be built in South Korea for the very first time. HiFamily, a South Korean protestant organization, will be opening the Andersen Memorial Park inside ‘W-Story’, a family theme park [...]

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Nanobiotix and MD Anderson Cancer Center Announce a Large-scale, Comprehensive Clinical Collaboration on NBTXR3

Paris, France, Cambridge, Massachusetts (USA) and Houston, Texas (USA), Jan. 7 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205) and The University of Texas MD Anderson Cancer Center today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers. [...]

Chosun University Hospital Turns to AI for Cancer Treatment

Chosun University Hospital Turns to AI for Cancer Treatment

GWANGJU, Nov. 5 (Korea Bizwire) — Chosun University Hospital in Gwangju announced on Sunday that it is using Watson for Oncology, a medical AI supercomputer designed by IBM Inc., for cancer treatment. Once the information about a patient along with the preliminary diagnosis is entered, Watson delivers the optimum method of treatment by analyzing its [...]

NANOBIOTIX: Positive Phase II/III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

NANOBIOTIX: Positive Phase II/III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Paris, France, and Cambridge, Massachusetts (USA), Oct. 19 (Korea Bizwire) – NANOBIOTIX (Euronext : NANO – ISIN : FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches in the treatment of cancer, presented NBTXR3 positive Phase II/III Act.in.sarc results in patients with locally advanced Soft Tissue Sarcoma at the European Society for Medical Oncology (ESMO) 2018 Congress [...]